Theseus Pharmaceuticals

Theseus Pharmaceuticals is a company developing pan-variant tyrosine kinase inhibitors (TKIs) designed to overcome treatment-resistant cancer mutations. We partnered with 22 Fillmore, a brand consultancy in the Bay Area, to deliver a full corporate rebrand that included a positioning platform, a new logo, identity system and company website among other touch points.